Skip to main content

Dudum Andrew's Form 4 filing

Hims & Hers Health, Inc. (HIMS) · filed Mar 18, 2025

Accession no.
0001773751-25-000101
Filed
Mar 18, 2025
Trade date
Mar 14-18, 2025
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 16 non-derivative transactions and 12 derivative transactions. Open-market sales total $8.62M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Dudum AndrewCIK 0001837796Director, Officer (Chief Executive Officer), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 14, 2025Class A Common StockMOption exerciseAcquired+176,311–F1–273,998Direct
Mar 14, 2025Class A Common StockFTax withholdingDisposed−97,551$33.14−$3,232,840.14176,447Direct
Mar 17, 2025Class A Common StockMOption exerciseAcquired+17,001$2.43+$41,312.43193,448Direct
Mar 17, 2025Class A Common StockSSaleDisposed−17,001$32.97F4−$560,522.97176,447Direct
Mar 17, 2025Class A Common StockMOption exerciseAcquired+50,000$2.43+$121,500226,447Direct
Mar 17, 2025Class A Common StockSSaleDisposed−50,000$35.28F5−$1,764,000176,447Direct
Mar 17, 2025Class A Common StockMOption exerciseAcquired+41,667$2.43+$101,250.81218,114Direct
Mar 17, 2025Class A Common StockSSaleDisposed−27,347$33.49F6−$915,851.03190,767Direct
Mar 17, 2025Class A Common StockSSaleDisposed−14,320$32.91F7−$471,271.2176,447Direct
Mar 17, 2025Class A Common StockMOption exerciseAcquired+16,667$2.43+$40,500.81193,114Direct
Mar 17, 2025Class A Common StockSSaleDisposed−16,667$32.96F8−$549,344.32176,447Direct
Mar 17, 2025Class A Common StockSSaleDisposed−2,792$33.01F9−$92,163.92173,655Direct
Mar 18, 2025Class A Common StockSSaleDisposed−57,713$33.75F10−$1,947,813.75115,942Direct
Mar 18, 2025Class A Common StockSSaleDisposed−21,047$34.13F11−$718,334.1194,895Direct
Mar 17, 2025Class A Common StockSSaleDisposed−40,447$33.55F12−$1,356,996.85387,349Indirect
Mar 17, 2025Class A Common StockSSaleDisposed−7,087$34.15F13−$242,021.05380,262Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 14, 2025Class A Common StockMOption exerciseDisposed−35,447$0.00$0283,572Direct
Mar 14, 2025Class A Common StockMOption exerciseDisposed−35,242$0.00$0140,968Direct
Mar 14, 2025Class A Common StockMOption exerciseDisposed−74,530$0.00$0894,358Direct
Mar 14, 2025Class A Common StockMOption exerciseDisposed−7,330$0.00$00Direct
Mar 14, 2025Class A Common StockMOption exerciseDisposed−108$0.00$00Direct
Mar 14, 2025Class A Common StockMOption exerciseDisposed−3,576$0.00$00Direct
Mar 14, 2025Class A Common StockMOption exerciseDisposed−1,789$0.00$00Direct
Mar 14, 2025Class A Common StockMOption exerciseDisposed−18,289$0.00$00Direct
Mar 17, 2025Class A Common StockMOption exerciseDisposed−17,001$0.00$0136,012Direct
Mar 17, 2025Class A Common StockMOption exerciseDisposed−50,000$0.00$01,248,067Direct
Mar 17, 2025Class A Common StockMOption exerciseDisposed−41,667$0.00$01,206,400Direct
Mar 17, 2025Class A Common StockMOption exerciseDisposed−16,667$0.00$01,189,733Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

Referenced by the price of 1 transaction in Table I.

F4

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $32.66 - $33.375. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $35.00 - $35.60. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F6

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $33.00 - $33.92. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F7

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $32.67 - $32.99. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F8

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $32.75 - $33.21. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F9

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $32.84 - $33.21. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F10

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $33.33 - $33.995. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F11

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $34.00 - $34.37. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F12

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $33.20 - $33.975. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F13

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $34.01 - $34.60. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)